Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
5,687,548
-
Share change
-
-356,426
-
Total reported value
-
$88,057,000
-
Price per share
-
$9.15
-
Number of holders
-
36
-
Value change
-
+$32,608,757
-
Number of buys
-
21
-
Number of sells
-
13
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q1 2021
As of 31 Mar 2021,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,687,548 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, Corriente Advisors, LLC, VANGUARD GROUP INC, Manatuck Hill Partners, LLC, Point72 Asset Management, L.P., Ikarian Capital, LLC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, Granite Point Capital Management, L.P., RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.